Infectious Disease
RSSArticles
-
Reader Survey Available
-
Infectious Disease Alert Updates
Surgeons Really Are Different; Short-Course Atovaquone/Proguanil for Malaria Prophylaxis; The High Cost of Chronic Lyme Treatment
-
Trimethoprim Sulfamethoxazole Plus Clindamycin for Treatment of Staphylococcus aureus Endocarditis
A before-and-after intervention study compared 170 patients treated with either oxacillin IV or vancomycin IV for six weeks (plus gentamicin IV given during the first five days) to 171 patients who were treated with TMP/SMZ IV plus clindamycin IV for the first week followed by TMP/SMZ PO (without clindamycin) to complete a six-week course. Mortality and hospital length of stay were significantly less in the TMP/SMZ-treated patients.
-
Checkpoint Inhibitors: The First Effective Therapy for Progressive Multifocal Leukoencephalopathy?
Enhancing the immune response with checkpoint inhibitors may be beneficial in the management of progressive multifocal leukoencephalopathy, a viral disease previously recalcitrant to therapy.
-
Significance of Pyuria in Children With Neurogenic Bladder
Pyuria is common in asymptomatic children with neurogenic bladders, especially after bladder surgery. The simple presence of pyuria does not necessarily indicate a need for antibiotic treatment.
-
Babesiosis — Increase in Reported Cases in the United States
The number of cases reported to the CDC from 2011-2015 has increased and there is concern about expansion of the areas in which it is transmitted.
-
Isavuconazole vs. Caspofungin for Candidemia
In a large, randomized, double-blind, multicenter clinical trial, researchers found that isavuconazole did not meet the primary endpoint of noninferiority compared to caspofungin for candidemia and invasive candidiasis.
-
Reader Survey Available
We’d love to hear from you how we can do better!
-
Bremelanotide Injection (Vyleesi)
Bremelanotide offers another FDA-approved treatment option for hypoactive sexual desire disorder with a different mechanism of action.
-
Changing Herpes Zoster Risk in Adults
Despite the introduction of two updated vaccines, the age-related incidence of herpes zoster in adults > 35 years of age has been increasing steadily.